SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-096250
Filing Date
2024-11-12
Accepted
2024-11-12 08:09:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea022061402-424b3_cero.htm 424B3 642694
2 GRAPHIC image_001.jpg GRAPHIC 10661
  Complete submission text file 0001213900-24-096250.txt   658702
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279156 | Film No.: 241443598
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)